Philip E Silkoff MD

Philip E Silkoff MD

Pulmonary Consultant Drug and Device Development

About

Boarded in Internal Medicine and Pulmonary Diseases Disease focus: Asthma, COPD, ILD, pulmonary hypertension Sleep medicine Closed loop respiratory devices Inhaled nitric oxide Exhaled nitric oxide Pulmonary consultant Noninvasive assessment of airway inflammation using exhaled NO, induced sputum bronchoscopy Phase 1-4 clinical development in asthma, COPD, sarcoidosis, IPF, and other pulmonary diseases Use of biomarkers to develop personalized therapies Interventional pulmonary devices e.g. lung volume reduction for emphysema, sleep apnea Biodefense projects against vesicants, radiation and application of the animal rule Medical writing and preparation of presentations/medical affairs Grant writing e.g NIH SBIR program Authoring publications

Country

United States

City

Boulder

Industry

Pharmaceuticals

Skill

Respiratory Disease, Grant Preparation, Contract Research Organization, Clinical Trials, Drug Development, Clinical Research, Asthma, Internal Medicine, Clinical Development, Pharmaceutical Industry, Pulmonology, Inflammation, Biotechnology, FDA, Immunology, Medical Affairs, Medical Devices, COPD, Biomarkers, Translational Medicine

Experience

Pulmonary Consultant Drug and Device Development

2020-7 - Present · 6 yrs 3 mos

Boulder, CO, USA

With a lengthy career in drug and device development, I provide expert input for drug and device development for pulmonary programs including clinical trial design, regulatory submissions, grant applications, and summaries of scientific evidence.

Third Pole Inc.

Chief Medical Officer

Third Pole Inc.

2016-3 - 2020-7 · 4 yrs 5 mos

Greater Philadelphia Area

Third Pole is focused on a novel technology to provide inhaled nitric oxide for modulation of pulmonary vascular tone.

Janssen R&D (JNJ)

Senior Medical Director

Janssen R&D (JNJ)

2008 - 2016-1 · 8 yrs

I have overseen multiple pulmonary development projects including biologics, oral and inhaled small molecules for asthma, COPD, IPF, sarcoidosis. I have been active in business development, and interventional pulmonology.

Johnson & Johnson Innovative Medicine

Senior Medical Director Pulmonary Medicine

Johnson & Johnson Innovative Medicine

LinkedIn
2008 - 2016 · 8 yrs

Springhouse, PA

Senior Medical Director focusing on monoclonal antibodies, small molecules, and inhalational technology in Respiratory Diseases including asthma, COPD, IPF, Sarcoidosis. Active in business development. Expert in measurement of exhaled nitric oxide. Winner of the Philip B Hoffman Research Award (JNJ)

AstraZeneca

Medical Director

AstraZeneca

LinkedIn
2004 - 2008 · 4 yrs

wilmington, DE

Medical Director, filed an sNDA for Symbicort in COPD eventually approved by FDA after I left.

National Jewish Health

Associate Professor

National Jewish Health

LinkedIn
1997 - 2004 · 7 yrs

Education

University of London

University of London

LinkedIn

Medicine

1971 - 1978 · 7 yrs
UCL

UCL

LinkedIn

Respiratory Medicine

Philip E Silkoff MD's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.